Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Conversion of 4,026 RTSN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Retension Pharmaceuticals, Inc. (RTSN) | Conversion | 4,026 | n/a |
| Aug 16, 2021 | WATERS CORP /DE/ (WAT) | Sale | 806 | $324.9K |
| Aug 13, 2021 | WATERS CORP /DE/ (WAT) | Sale | 4,000 | $1.59M |
| May 25, 2021 | WATERS CORP /DE/ (WAT) | Sale | 1,161 | $369.5K |
| Jan 6, 2021 | WATERS CORP /DE/ (WAT) | Grant/Award | 439 | n/a |
| Nov 10, 2020 | WATERS CORP /DE/ (WAT) | Exercise/Conversion | 4,000 | $312.4K |
| Jan 3, 2020 | WATERS CORP /DE/ (WAT) | Exercise/Conversion | 4,000 | $246.5K |